A Study to Evaluate the Safety and Efficacy of IPX203 in Parkinson's Disease Participants With Motor Fluctuations

Clinical trial NCT03670953 · COMPLETED

Trial details

NCT number: NCT03670953
Sponsor: Impax Laboratories, LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Parkinson's Disease (Disorder)

Start date: 2018-11-06
Primary completion: 2021-06-15
Enrollment: 630

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.